Used in pharmaceutical synthesis as a chiral building block for developing biologically active compounds, particularly in the production of neuroactive agents and central nervous system therapeutics. Its structure supports the development of inhibitors targeting specific enzymes and receptors due to the presence of a functionalized pyrrolidine ring. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies, especially in optimizing drug candidates for improved selectivity and metabolic stability. Also utilized in the preparation of radiolabeled derivatives for receptor binding assays and imaging applications.